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Introduction: The presence in serum of cardiac markers with a high sensivity for the damage of myocardic such as 
cardiac troponin T or I (cTnT or cTnI) or isoensymes of creatine kinase MB (CK-MB) give the opportunity to the doctors to diagnose the acute myocardial infarction 
(AMI) and also to give a prognosis on the patients performance. Aim: The evaluation of performance of cardiac enzyme according to time and also the connection 
between the values of the enzymes and the pain characteristics or the infarction lesion in patients with AMI in Elbasan region.  Methodology. The study is performed in 
the regional hospital of Elbasan, in the department of cardiology during 2009 and is involved patients diagnosed with new AMI. It is performed the measurement of the 
cardiac enzymes profile (CK, CK-MB, troponin I and T) in some period of time and the pain characteristics or lesion of AMI in the moment of hospitalized (according to 
the determination of  cardiologist). SPSS 16 is used to analyze the data. p<0.05 is significantly for the statistics view.  Results. 65 patients with AMI had taken part in the 
study. The values of cardiac enzymes in patients decreased in significant way based on days (p<0.05) but have a different model of normalization. For all the cardiac 
enzymes included in the study don’t have significant changes in their average values according to the type of the pain (t test, p >0.05). The average values of cardiac 
enzymes in the hospitalized moment are significantly lower in patients who have a continuance of the pain less than six hours and who have had a lower acute 
myocardial infarction (p<0.05 in t- test). Conclusions. Cardiac enzymes should be considered together to better predict the time occurrence of a new AMI. The high 
values of cardiac enzymes are found in the patients with a continuance of pain more than six hours and a wide lesion of myocardial infarction, defining these patients as 
the most dangerous group for unfavorable results.   
 
 
Introduction 
 
Patients that have a moderate probability for coronary acute syndrome are performed analyzes for the 
damage markers of the myocardial such as: cardiac troponins T or I (cTnT or cTnI) or isoenzymes of creatine 
kinase (CK-MB). The presence in serum of cardiac markers with high sensitivity for the damage of myocard 
give the opportunity to the doctors to diagnose the myocardial infarction in one third of the patients that in the 
past will not fill the criteria for myocardial infarction (1, 2). 
 
Approximately, one fourth of the patients with myocardial infarction do not experience the classic pain 
chest and the event cannot be notice in the EKG changes, the Q waves are not recorded which are pathological. 
The undiagnosed EKG are recorded at approximately in half of the patients that have experienced suspicion pain 
chest for myocardial infarction, patients that in the end are diagnosed with myocardial infarction.  
 
Patients that are hospitalized with the syndrome of myocardial infarction, less than 20% of them are 
diagnosed that has experienced before myocardial infarction. In the majority of the patients, the cardiac markers 
need to be measured in time intervals, to be more certain about the diagnosis or to exclude the myocardial 
infarction diagnosis; such measurements will also be very effective for the infarction size.  
 
The knowledge of the performance of the tracking cardiac enzymes play an important role not only in the 
diagnosis but also in the long term follow up of the patients with AMI (1, 2, 11). 
 
 Aim 
 The evaluation of the performance of cardiac enzymes according to time and also the connection between 
enzymes values and the pain characteristics or infarction lesion in patients with AMI in Elbasan region. 
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  Methodology 
 
  The study is designed as a transversal time series for the evaluation of the changes in tracking enzymes 
of AMI and transversal to study the connection between the values of marked enzymes and clinic signs (pain) 
and lesion characteristics of AMI. In the study are included patients who are admitted in the regional hospital of 
Elbasan and are treated for a new AMI during year 2009. The study is performed in the department of 
cardiology. The data are gathered during the hospital staying of the patients. Bio-chemical data on the cardiac 
enzymes profile (CPK, MB-CPK, troponin I and T) are remeasured in time intervals according to each enzymes 
(hospitalized, after 24, 48, 96 hours and until  and 10-14 days for troponin) 
 
  The data were gathered based on the type of pain (typical, atypical) duration of the pain (less or more 
than 6 hours), lesion size (little or wide, defined by the doctor in the medical), location(anterior, posterior or 
other). 
  SPSS 16 is used to study the connection of the biochemical profile values according to the time, clinic 
and lesion characteristics. T test or ANOVA are used to evaluate the changes in the enzymes values according to 
the enzymes measurements using the spearmen correlation technic, to highlight if there is a change between the 
average values of the enzymes according to the pain characteristics or lesion. A p<0.05 is considered significant 
for the statistics view. 
 
  Results 
 
  Sixty five (65) patients with a new AMI have taken part in the study. In the above graphics, the 
performance of the cardiac enzymes in patients with myocardial infarction acute according to the time of 
measurement is given. 
 
Graphic 1. Performance of average values of troponin T according to time. 
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  After a significant rise of the troponin T values within the first day, there is a significant decrease in the 
sixth day and it reached normal values on the tenth day(inANOVA; p<0.05). 
 
Graphic 2. Performance of average troponin I values according time. 
 
 Even for troponin I, a significant rise of the average values from 0.24 ng/dl to 2.47 ng/dl during the first 
24 hours and after there is a reduction that is more sensitive during the first day to seventh day and less from 
seventh day to tenth day and there is a normalization of the values in the 14th day. The performance of troponin 
I values according to the days is significant in ANOVA post hoc test Bonferroni (p<0.05). 
Graphic 3. The performance of average values of mbCK according time. 
 
 Volume 4, issue 6, 2015  e-ISSN: 1857-8187   p-ISSN: 1857-8179                                                                                                            
Page | 60  
 Anglisticum Journal (IJLLIS), Volume: 4 | Issue: 6, June 2015 |  
 
 During the first 24 hours, there is a rise of the cardiac enzymes values mbCK, but in the following days 
there is a decrease of the average values until its normalization in the fourth day. From the statistics view, this 
change of values of mbCK is significant (ANOVA p<0.05). 
 
Graphic 4. The performance of average values of CK according time. 
 
  
 Apart from other cardiac enzymes, the values of CK do not rise during the performance of the 
myocardial infarction. They decrease and normalize within the third day of the hospitalization. The decrease of 
the values of CK from one measurement to the other is significant for the statistics. 
 
 In the first table, it is shown the average of cardiac enzymes according to the type of the pain (atypical 
or typical).For all cardiac enzymes taken in the study, there isn’t significant changes in the average values 
according the type of pain (t test p >0.05). 
 
Table 1. The average of cardiac enzymes in the moment of hospitalization according to the type of pain. 
 Type of pain  
 Typical Atypical  
 Average+SD Average +SD P value* 
CK (U/L) 518.5 +230 599.88+273 0.202 
Troponin T (ng/dl) 0.135+0.115 0.1812+0.09 0.1 
Troponin I (ng/dl) 0.23675+0.15 0.29+0.14 0.16 
mbCK (U/L) 52+18 61.8+24.5 0.09 
          *t test 
            p<0.05 is considered significant 
 
The average values of the cardiac enzymes in the moment of hospitalization are significant smaller in 
patients that have the duration of the pain less than six hours (see table 2). 
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Table 2. The average of cardiac enzymes in the moment of hospitalization according to the pain. 
 
 Pain duration  
 Less than 6 hours More than 6 hours 
 Average+SD Average+SD p value* 
CK (U/L) 478.8+219.8 709.5+240 0.001 
Troponin T (ng/dl) 0.135+0.114 0.191+0.09 0.048 
Troponin I (ng/dl) 0.231+0.15 0.316+0.10 0.033 
MbCK (U/L) 49.6+18.9 70.8+19.9 0.001 
         *t test 
           p<0.05 is considered significant 
 
Tabela 3. The average of the cardiac enzymes in the moment of hospitalization according the size of the 
myocardial infarction. 
 Infarction size  
 Wide Small  
 average+SD average+SD p value* 
CK (U/L) 729.5+221.9 451.35+205.5 0.001 
Troponin T (ng/dl) 0.233+0.137 0.108+0.06 0.T001 
Troponin I (ng/dl) 0.346+0.14 0.20+0.12 0.001 
MbCK (U/L) 72.8+20.1 47.02+16 0.001 
            *t test 
              p<0.05 is considered significant 
 
Patients with myocardial infarction acute with a wide lesion, the average values of cardiac enzymes are 
significant higher than in patients who have had a myocardial infarction acute in smaller sizes (p<0.05 në t test). 
 
Table 4. The average of cardiac enzymes in the moment of hospitalization according to the location of the 
myocardial infarction. 
 
 Location  
 Anterior Inferior Other P value* 
 Average+SD Average+SD Average+SD  
CK (U/L) 605+257 531.1+239.4 335+145 0.104 
Troponin T (ng/dl) 0.17+0.09 0.149+0.12 0.08+0.02 0.393 
Troponin I (ng/dl) 0.291+0.15 0.24+0.15 0.16+0.05 0.18 
MbCK (U/L) 61.1+24 53.7+18.1 43.2+27 0.193 
             *anova 
                           p<0.05 is considered significant 
 
Apart from the location of the myocardial infarction, anterior, posterior or other, the average values of 
the cardiac enzymes do not have significant changes between location (p>0.05 in ANOVA) (see Table 4).  
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Table 5. The average of cardiac enzymes in the moment of hospitalization according to the pain lasting. 
 Pain lasting  
 Lasting Not lasting P value* 
 Average+SD Average+SD  
CK (U/L) 584.5+252 494.2+237.7 0.157 
Troponin T (ng/dl) 0.167+0.128 0.126+0.062 0.112 
Troponin I (ng/dl) 0.28+0.16 0.21+0.108 0.051 
MbCK (U/L) 59.15+21 51.3+21.6 0.157 
             *t test 
               p<0.05 is considered significant 
 
 In table 5 are shown the values of cardiac enzymes in the moment of hospitalization according to the 
lasting of the pain. Patients that had a lasting pain had higher values of the cardiac enzymes then patients that 
reported not lasting pain, but for statistics these changes are not significant (p>0.05 in t test). 
 
Discussion and conclusion  
 
Through the tracking cardiac enzymes of the lesion location in the cardiac muscle, troponin I and T and 
also CK-MB are cardiac enzymes that reach their peak within 24 hours from the hospitalization, while CK is an 
enzyme that within 24 hours is considerably reduced from the initial values in the moment of hospitalization of 
the patients.So, these three enzymes are the significant markers that show the myocardial infarction location 
even 24 hours after the infarction occurrence, while CK could not be used as a marker for the infarction location 
after 96 hours. Our study conclusion are in accordance with other studies performed in this field concluding that 
troponin I, T and CK-MB are some significant markers for the myocardial infarction location (3, 4, 5). 
 
Troponin T and I are cardiac enzymes that need more time to come back at their normal values than CK 
and CK-MB and for this reason, troponin T and I could be the markers that show the location of the myocardial 
infarction even after one week. 
 
Only a combination of the cardiac enzymes values in the moment of hospitalization could orientate the 
location of AMI. The conclusions of our study are comparable with other studies performed in this field that 
emphasize the values of the cardiac markers in the definition of the infarction time occurrence (3, 4, 5). 
 
Cardiac enzymes are a precise mirror of the clinic situation and the short term of myocardial infarction 
history until the hospitalization of the patient, and also to highlight the results in the patients that have an wide 
infarction size the values of the cardiac enzymes are higher compared with the patients who have a small 
infarction lesion size. 
 
Patients who have a typical or atypical pain have the same average values of the cardiac enzymes, 
which means that the type of the pain does not define the lesion size.  
 
It is the pain duration that is accompanied with the high values of the cardiac enzymes. This is 
explained that the more time the patients have passed with the pain or have started the infarction process, the 
higher the risk of the cardiac tissue affection and consequently is accompanied with a high level of cardiac 
enzymes such as troponin I, T, CK and mbCK. This is consistent and with the result of comparative the values of 
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the cardiac enzymes according to the lesion size, the bigger the lesion, the higher the level of the cardiac 
enzymes (4, 6, 7, 11, 9). 
 
The higher the cardiac enzymes values in the moment of hospitalization the poorer the long term 
prognosis of the patients with AMI, because the higher values of the enzymes are closely connected in the 
present of a wide lesion, this resulting in showing in the medical centers after a considerable time that worsen 
the long term prognosis of the AMI patients. This could be explained even with the fact that the patients with 
atypical pain came even later neglecting such a pain (8, 10). 
 
As a conclusion, cardiac enzymes should be valuated together to better orientate in terms of AMI 
location. The higher values of the cardiac enzymes found in the patients with the duration of the pain with more 
than six hours and a wide lesion of myocardial infarction, define these patients as a risker group for unfavorable 
results. 
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